Development of a Clinical Disease Activity Measure for Juvenile Localized Scleroderma.

被引：0

作者：

Li, Suzanne C. ^{[1
]}

Torok, Kathryn S. ^{[2
]}

Pope, Elena ^{[3
]}

Stewart, Katie G. ^{[4
]}

Higgins, Gloria C. ^{[5
]}

Rabinovich, Egla C. ^{[6
]}

O'Neil, Kathleen M. ^{[7
]}

Foeldvari, Ivan ^{[8
]}

Haines, Kathleen A. ^{[1
]}

Jacobe, Heidi ^{[9
]}

Punaro, Marilynn G. ^{[4
]}

Laxer, Ronald M. ^{[3
]}

Nyirenda, Themba ^{[1
]}

Wittkowski, Knut M. ^{[10
]}

机构：

[1] Hackensack Univ Med Ctr, Hackensack, NJ USA

[2] Univ Pittsburgh Med Ctr, Pittsburgh, PA USA

[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada

[4] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA

[5] Nationwide Childrens Hosp, Columbus, OH USA

[6] Duke Univ Med Ctr, Durham, NC USA

[7] Okla Univ Hlth Sci Ctr, Oklahoma City, OK USA

[8] Hamburger Zentrum Kinder & Jugendrheumatol, Hamburg, Germany

[9] UT SW Med Ctr Dallas, Dallas, TX USA

[10] Rockefeller Univ, New York, NY 10021 USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2453

引用

页码：S955 / S956

页数：2

共 50 条

[1] A prospective clinical and pathological study on efficacy of methotrexate/corticosteroid in juvenile localized scleroderma.
Meneghesso, D
Falcini, F
Martini, G
Montesco, MC
Pigozzi, B
Simonini, G
Zacchello, F
Zulian, F
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S533 - S533
[2] Role of chimerism in a monozygotic twin with juvenile localized scleroderma.
McNallan, K
Reed, AM
Martini, G
Zulian, F
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S303 - S303
[3] Juvenile systemic scleroderma.
Martini A.
Current Rheumatology Reports, 2001, 3 (5) : 387 - 390
[4] Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma
Torok, Kathryn S.
Li, Suzanne C.
Kelsey, Christina
Becker, Mara L.
Dedeoglu, Fatma
Fuhlbrigge, Robert C.
Higgins, Gloria
Hong, Sandy D.
Ibarra, Maria F.
Laxer, Ronald M.
Mason, Thomas G., II
Punaro, Marilynn G.
Pope, Elena
Rabinovich, Egla C.
Stewart, Katie G.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S860 - S860
[5] JUVENILE LOCALIZED SCLERODERMA: ASSESSING DISEASE ACTIVITY AND TREATMENT
Zulian, F.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 49 - 50
[6] Durometry as an outcome measure in juvenile localized scleroderma
Poff, S.
Li, S. C.
Kelsey, C. E.
Foeldvari, I. .
Torok, K. S.
BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (01) : 228 - 230
[7] Systemic manifestations in localized scleroderma.
Zulian F.
Current Rheumatology Reports, 2004, 6 (6) : 417 - 424
[8] Disease Course of Juvenile Localized Scleroderma
Adly, Merna
Prajapati, Vimal
Stevenson, Rebeka
Lethebe, Brendan
Milovanova, Katia
Luca, Nadia
JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1141 - 1141
[9] Mechanisms of Disease: Scleroderma.
Gabrielli, Armando
Avvedimento, Enrico V.
Krieg, Thomas
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (19): : 1989 - 2003
[10] Initial Evaluation of a Localized Scleroderma (LS) Clinical Activity Measure.
Li, Suzanne C.
Torok, Kathryn S.
Kelsey, Christina
Becker, Mara L.
Dedeoglu, Fatma
Fuhlbrigge, Robert C.
Higgins, Gloria C.
Hong, Sandy D.
Ibarra, Maria F.
Laxer, Ronald M.
Mason, Thomas G., II
Punaro, Marilynn G.
Pope, Elena
Rabinovich, Egla C.
Stewart, Katie G.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S851 - S852

← 1 2 3 4 5 →